Piperidolate hydrochloride is an antimuscarinic, Also a potential inhibitor of human glutathione transferase P1-1. Piperidolate HCl could restrain the abnormal activity caused by acetylcholine. inhibits intestinal cramp induced by acetylcholine (rats and dogs).

Leucomalachite green is used in detecting latent bloodstains and in the forensic field because of convenience and cost/time-effectiveness.

Sodium acetrizoate (rINN, trade names Urokon, Triurol and Salpix), the sodium salt of acetrizoic acid, is a high-osmolality, water-soluble, iodine-based radiographic contrast medium.

t-boc-N-amido-PEG6-azide is a PEG derivative containing an azide group and Boc-protected amino group. The azide group can react with alkyne, BCN, DBCO via Click Chemistry to yield a stable triazole linkage. The Boc group can be deprotected under mild acidic conditions to form the free amine. PEG Linkers may be useful in the development of antibody drug conjugates.

Biotin-HPDP, also known as N-[6-(Biotinamido)hexyl]-3’-(2’-pyridyldithio)-propionamide, is a sulfhydryl reactive biotinylation reagent with a long chain, cleavable spacer arm.

C.I. Vat Yellow 2 is a yellow dye.

C.I. Solvent Green 3 is a green dye, an is a green dye, an anthraquinone derivative..

Mal-PEG5-acid is a PEG derivative containing a maleimide group with a terminal carboxylic acid. The hydrophilic PEG spacer increases solubility in aqueous media. The maleimide group will react with a thiol group to form a covalent bond, enabling the connection of biomolecule with a thiol. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond.

THP-PEG5 is a PEG linker.

Saccharin sodium is a type of artificial or nonnutritive sweetener. It is 200 to 700 times sweeter than sucrose but has a bitter aftertaste. Saccharin and its salts do not occur naturally. Saccharin sodium is used in the production of various foods and pharmaceutical products including soft drinks, candy, biscuits, jams, chewing gum, tinned fruit, medicine and toothpaste.

Butylated hydroxytoluene is di-tert-butyl PHENOL with antioxidant properties.

Methylamino-PEG4-acid HCl salt is a PEG derivative containing a carboxylic acid with a methylamine group. The hydrophilic PEG spacer increases solubility in aqueous media. The methylamine group is reactive with carboxylic acids, carbonyls (ketone, aldehyde) etc. The terminal carboxylic acid can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond.

VP3.15 Dihydrobromide is a novel dual phosphodiesterase (PDE)7- glycogen synthase kinase (GSK)3 inhibitor.

t-Boc-N-amido-PEG1-amine is a PEG derivative containing an amino group and Boc-protected amino group. The amino group is reactive with carboxylic acids, activated NHS esters, carbonyls (ketone, aldehyde) etc. The Boc group can be deprotected under mild acidic conditions to form the free amine. PEG Linkers may be useful in the development of antibody drug conjugates.

Cobaltocene is used to catalyze the preparation of pyridines from alkynes and nitriles. It is also used as a paint drier and as an oxygen stripping agent.

Diphenyl sulfone is an organosulfur compound with the formula (C?H?)?SO?. It is a white solid that is soluble in organic solvents. It is used as a high temperature solvent.

Azido-PEG7-alcohol is a PEG derivative containing an azide group and a terminal hydroxyl group. The hydrophilic PEG spacer increases solubility in aqueous media. The azide group can react with alkyne, BCN, DBCO via Click Chemistry to yield a stable triazole linkage. The hydroxyl group enables further derivatization or replacement with other reactive functional groups.

Benzyl-PEG4-acid is a Benzyl PEG Linker. PEG Linkers may be useful in the development of antibody drug conjugates.

1-Acetylferrocene is an organoiron compound with the formula Fe. It consists of ferrocene substituted by an acetyl group on one of the cyclopentadienyl rings. It is an orange, air-stable solid that is soluble in organic solvents.

Sulfo-NHS-LC-Biotin, or Sulfosuccinimidyl 6-(biotinamido) Hexanoate, is a long chain, water soluble biotinylation reagent that is reactive toward primary amine groups. Similar to Sulfo-NHS-Biotin, Sulfo-NHS-LC-Biotin is designed to target cell surface proteins.

NHI-2 is a LDHA inhibitor. It acts by reducing lactate production in HeLa cells.

L-Linalool is the key volatile compound of jasmine tea, spruce essential oil and young leaves of Litchi chinensis Sonn.

Bis-PEG9-acid is a PEG derivative containing two terminal carboxylic acid groups. The terminal carboxylic acids can be reacted with primary amine groups in the presence of activators (e.g. EDC, or DCC) to form a stable amide bond.

BAPTA Tetrasodium is a selective fluorescent chelator for calcium.

Benzyl-PEG2-amine is a Benzyl PEG Linker. PEG Linkers may be useful in the development of antibody drug conjugates.

Althiomycin, also known as matamycin, is a thiazole antibiotic, effective against Gram-positive and Gram-negative bacteria. Isolated from Streptomyces matensis, Althiomycin was first described by Margalith et al. in 1959. It acts a protein synthesis inhibitor and its site of action is the 50S subunit of the bacterial ribosome.

Decanoyl-coenzyme A is a thioester of decanoic acid and CoA. It inhibits the activity of citrate synthase (CS) and glutamate dehydrogenase (GDH) in mitochondria. Decanoyl CoA also binds the fatty acid metabolism regulator protein (FadR) promoter in E. coli. It is produced during isomerase-dependent β-oxidation of oleic acid.

Acibenzolar-S-methyl is a fungicide that works by activating a plant's own defense system by increasing the transcription of W-box controlled genes such as CAD1, NPR1 and PR2. It is a methyl derivative of acibenzolar.

Decloxizine hydrochloride is a biochemical.

Dexrazoxane hydrochloride is a cardioprotectant. Studies have shown that usage of this drug before anthracycline chemotherapy in pediatric patients with AML may improve cardiac function indices such as ejection fraction and shortening fraction. Adding dexrazoxane to doxorubicin in adjuvant therapy patients may lead to higher rates of bone marrow suppression, more febrile neutropenia events, and dose reductions.